KYVERNA THERAPEUTICS INC (KYTX) Forecast, Price Target & Analyst Ratings

NASDAQ:KYTX • US5019761049

Current stock price

9.09 USD
+0.14 (+1.56%)
At close:
8.9031 USD
-0.19 (-2.06%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for KYVERNA THERAPEUTICS INC (KYTX).

Forecast Snapshot

Consensus Price Target

Price Target
$28.76
+ 216.44% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 1, 2026
Period
Q4 / 2025
EPS Estimate
-$0.88
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
85.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$28.76
Upside
+ 216.44%
From current price of $9.09 to mean target of $28.76, Based on 12 analyst forecasts
Low
$20.20
Median
$30.60
High
$34.65

Price Target Revisions

1 Month
0.00%
3 Months
11.68%

Price Target Summary

12 Wall Street analysts provided a forecast for the next 12 months for KYTX. The average price target is 28.76 USD. This implies a price increase of 216.44% is expected in the next year compared to the current price of 9.09.
The average price target has been revised upward by 11.68% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

KYTX Current Analyst RatingKYTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

KYTX Historical Analyst RatingsKYTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
85.00%
KYTX was analyzed by 12 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about KYTX.
In the previous month the buy percentage consensus was at a similar level.
KYTX was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-12-16Wells FargoMaintains Overweight -> Overweight
2025-12-04Morgan StanleyMaintains Overweight -> Overweight
2025-10-30Wells FargoMaintains Overweight -> Overweight
2025-10-27HC Wainwright & Co.Maintains Buy -> Buy
2025-10-08Wells FargoMaintains Overweight -> Overweight
2025-08-29HC Wainwright & Co.Maintains Buy -> Buy
2025-08-20William BlairInitiate Outperform
2025-05-27HC Wainwright & Co.Upgrade Neutral -> Buy
2025-04-03HC Wainwright & Co.Maintains Neutral -> Neutral
2025-04-01Morgan StanleyMaintains Overweight -> Overweight
2024-11-20HC Wainwright & Co.Maintains Neutral -> Neutral
2024-11-15Wells FargoMaintains Overweight -> Overweight
2024-10-10UBSInitiate Buy
2024-09-19HC Wainwright & Co.Reiterate Neutral -> Neutral
2024-08-15HC Wainwright & Co.Maintains Neutral -> Neutral
2024-07-31JP MorganMaintains Overweight -> Overweight
2024-07-16HC Wainwright & Co.Reiterate Neutral -> Neutral
2024-07-03HC Wainwright & Co.Initiate Neutral
2024-03-04JP MorganInitiate Overweight
2024-03-04Morgan StanleyInitiate Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 1, 2026
Period
Q4 / 2025
EPS Estimate
-$0.88
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
0.51%
Number of Analysts
8

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
6.70%

Next Earnings Summary

KYTX is expected to report earnings on 4/1/2026. The consensus EPS estimate for the next earnings is -0.88 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
KYTX revenue by date.KYTX revenue by date.
5.656M7.025M
24.20%
-100.00%		27.468M52.836M
92.35%		178.04M
236.97%		534.23M
200.06%		868.94M
62.65%		1.41B
62.27%		1.79B
26.95%
EBITDA
YoY % growth
KYTX ebitda by date.KYTX ebitda by date.
-25.76M-28.333M
-9.99%		-63.196M
-114.23%		-145.973M
-132.07%		-173.469M
-23.14%		-187.003M
-7.80%		-193.498M
-3.47%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
KYTX ebit by date.KYTX ebit by date.
-26.346M-29.384M
-11.53%		-63.082M
-112.38%		-144.88M
-129.14%		-178.913M
-25.11%		-199.15M
-11.31%		-216.452M
-8.69%		-419.22M
-93.68%		-485.52M
-15.82%		-195.84M
59.66%		N/AN/AN/A
Operating Margin
KYTX operating margin by date.KYTX operating margin by date.
-465.81%-418.28%N/AN/AN/AN/A-788.02%-793.44%-272.70%-36.66%N/AN/AN/A
EPS
YoY % growth
KYTX eps by date.KYTX eps by date.
N/AN/A-8.79-3.36
60.53%		-3.78
-8.91%		-3.56
5.85%		-3.29
7.41%		-4.43
-34.52%		-4.20
5.18%		-1.35
67.84%		2.37
275.09%		6.70
183.19%		9.10
35.77%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.88
0.51%		-0.91
12.11%		-0.91
6.41%		-0.96
-12.80%		-0.97
-10.68%		-0.96
-5.92%		-0.99
-8.99%		-1.02
-6.38%		-1.04
-7.37%
Revenue
Q2Q % growth		N/AN/AN/AN/A
EBITDA
Q2Q % growth		-39.78M
-2.24%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-44.549M
-8.55%		-48.068M
-1.39%		-49.343M
-11.11%		-54.06M
-39.59%		-56.483M
-26.79%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

KYTX Yearly Revenue VS EstimatesKYTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B
KYTX Yearly EPS VS EstimatesKYTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 -5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
1.66%
EPS Next 5 Year
-3.90%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-10.13%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

KYVERNA THERAPEUTICS INC / KYTX Forecast FAQ

What is the price target for KYTX stock?

12 analysts have analysed KYTX and the average price target is 28.76 USD. This implies a price increase of 216.44% is expected in the next year compared to the current price of 9.09.

When does KYVERNA THERAPEUTICS INC (KYTX) report earnings?

KYVERNA THERAPEUTICS INC (KYTX) will report earnings on 2026-04-01, after the market close.

Can you provide the consensus estimates for KYVERNA THERAPEUTICS INC next earnings?

The consensus EPS estimate for the next earnings of KYVERNA THERAPEUTICS INC (KYTX) is -0.88 USD and the consensus revenue estimate is 0 USD.